# Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

> **NCT00008034** · PHASE1 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** cyclophosphamide
- **DRUG:** epirubicin hydrochloride

## Key facts

- **NCT ID:** NCT00008034
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2000-12
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008034, "Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00008034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*